|30 Sep 2022
|We are pleased to inform you that second plant out of the two plants set-up for manufacturing of Drug Intermedidates / Active Pharmaceuticals Ingredients (APIs) at the Company's new green field manufacturing unit being set up at Dewas (Madhya Pradesh) with a capital outlay of about Rs. 250 crores has commenced trial production on 30th September, 2022.
|View all announcements for IPCA LABORATORIES LTD.
|Source: BSE India